Mr. Gallagher serves in leadership roles including Co-Founder, Board Director and Chief Business Officer with several biotech companies: Retrosense Therapeutics (acquired by Allergan), Zavante Therapeutics, OrPro Therapeutics, Kalyra and Zeno Pharmaceuticals. He was previously Managing Director of Nerveda, LLC, an early stage life science seed fund he co-founded in June 2007, and a Board Director at DioGenix and Sorrento Therapeutics. In an earlier position, Mr. Gallagher was Vice President of Marketing at Verus Pharmaceuticals, a privately held specialty pharmaceutical company in San Diego, California. Prior to Verus, he held positions of increasing management responsibilities at CV Therapeutics and Dura Pharmaceuticals. Mr. Gallagher holds an M.B.A. from the University of San Diego and a B.S. in Business Administration from Ohio University.